ATP2A2 — ATPase Sarcoplasmic/Endoplasmic Reticulum Ca2+ Transporting 2
Overview
Mermaid diagram (expand to render)
ATP2A2 encodes SERCA2 (Sarco/Endoplasmic Reticulum Calcium ATPase 2), a critical calcium pump that transports calcium from the cytosol into the endoplasmic reticulum (ER)[@berridge2020]. This protein is essential for maintaining cellular calcium homeostasis, a fundamental process for neuronal function and survival. SERCA2 plays vital roles in ER calcium storage, protein folding, cellular signaling, and synaptic transmission.
The ATP2A2 gene is located on chromosome 12q24.11 and produces multiple isoforms through alternative splicing. SERCA2a is predominantly expressed in cardiac and skeletal muscle, while SERCA2b is the ubiquitous isoform found in all tissues including the brain. In neurons, SERCA2b is particularly important for maintaining ER calcium stores that are essential for cellular signaling, protein quality control, and synaptic function["@giacomomello2019"].
Dysregulation of SERCA2 function has been implicated in multiple neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease["@kiviluoto2019"]. Additionally, mutations in ATP2A2 cause Darier disease, an autosomal dominant skin disorder often accompanied by neuropsychiatric manifestations.
<div class="infobox">
| Attribute | Value |
|---|---|
| Gene Symbol | ATP2A2 |
| Protein | SERCA2 (Sarco/Endoplasmic Reticulum Calcium ATPase 2) |
| Chromosomal Location | 12q24.11 |
| NCBI Gene ID | 488 |
| UniProt ID | Q93014 |
| Aliases | SERCA2, ATP2A2, DKFZp434K1210 |
| Gene Family | P-type ATPase family (ion transport) |
| Expression | Ubiquitous, high in brain, heart, skeletal muscle |
</div>
Normal Function
Calcium Pump Activity
SERCA2 is a P-type ATPase that actively transports calcium ions from the cytosol into the ER lumen using ATP hydrolysis[@berridge2020]. This process is crucial for:
- ER calcium homeostasis: Maintains high ER calcium concentrations (100-500 μM vs. ~100 nM cytosolic)
- Cell signaling: Enables calcium release through IP3 and ryanodine receptors
- Protein folding: Chaperone function requires calcium as a cofactor
- Cellular viability: Prevents calcium toxicity and ER stress
The ATP2A2 gene produces multiple protein isoforms through alternative splicing:
- SERCA2a: Cardiac and slow-twitch muscle specific, critical for cardiac function
- SERCA2b: Ubiquitous isoform with extended C-terminal 12-amino acid tail (PLN regulatory domain)
- SERCA2c: Minor isoform expressed in various tissues
The neuronal isoforms are predominantly SERCA2b, which has higher apparent affinity for calcium and is regulated by phospholamban (PLN) in some cell types.
Regulatory Mechanisms
SERCA2 activity is regulated at multiple levels:
Phospholamban (PLN): Phosphorylation relieves inhibition in cardiac myocytes
Calmodulin: Calcium-calmodulin can modulate activity
Oxidative modification: Oxidation can inhibit or stimulate activity depending on context
Transcriptional regulation: Multiple transcription factors control expressionRole in Neurodegeneration
Alzheimer's Disease
SERCA2 dysfunction is increasingly recognized as an important contributor to Alzheimer's disease pathogenesis[@calciumad2022][@tau2024]:
Calcium Dysregulation:
- ER calcium depletion reduces calcium signaling capacity
- Impaired IP3-mediated calcium release affects synaptic plasticity
- Disrupted calcium homeostasis contributes to tau pathology
- SERCA2 expression is reduced in AD brain tissue
ER Stress:
- Calcium depletion impairs protein folding capacity
- Accumulation of misfolded proteins triggers ER stress response
- Chronic ER stress leads to apoptotic signaling
- Links amyloid pathology to neuronal death
Tau Pathology:
- SERCA dysfunction exacerbates tau hyperphosphorylation
- Calcium-dependent kinases (CaMKII, GSK-3β) become dysregulated
- Impaired autophagy due to ER stress increases tau aggregation
- Bidirectional relationship between calcium dysregulation and tau
Parkinson's Disease
Calcium dysregulation is a hallmark of PD pathogenesis[@pdcalcium2023]:
Neuronal Vulnerability:
- Dopaminergic neurons have high calcium influx through L-type channels
- SERCA2 dysfunction exacerbates calcium overload
- Mitochondrial dysfunction synergizes with ER calcium dysregulation
Alpha-Synuclein Toxicity:
- SERCA2 inhibition accelerates α-synuclein aggregation
- ER stress promotes α-synuclein misfolding
- Calcium dysregulation affects autophagy of α-synuclein
Mechanisms:
- Impaired ER calcium storage reduces cellular resilience
- Synaptic calcium signaling disrupted
- Leads to neurotransmitter dysfunction
Other Neurodegenerative Conditions
SERCA2 dysfunction has been implicated in:
- Huntington's disease: ER calcium dysregulation contributes to mutant huntingtin toxicity
- Amyotrophic lateral sclerosis (ALS): Calcium homeostasis impaired in motor neurons
- Frontotemporal dementia: Linked to tau pathology and ER stress
- Spinocerebellar ataxias: Calcium signaling abnormalities
Molecular Mechanisms
ER Calcium Depletion
Loss of SERCA2 function leads to[@kaufman2020]:
Reduced ER calcium stores: Decreases signaling capacity
Increased cytosolic calcium: Can trigger toxicity pathways
Impaired calcium signaling: Affects all downstream pathwaysER Stress Response
ER calcium depletion triggers the unfolded protein response (UPR)[@erstress2023]:
- PERK pathway: Attenuates protein translation
- IRE1 pathway: Activates XBP1 splicing and CHOP expression
- ATF6 pathway: Upregulates ER chaperones
Chronic UPR activation leads to apoptosis through CHOP-mediated cell death.
Synaptic Dysfunction
In neurons, SERCA2 is critical for[@synapse2024]:
- Synaptic vesicle cycling: Calcium-regulated exocytosis requires ER calcium
- Dendritic spine function: Calcium signaling in spines
- Long-term potentiation: Calcium-dependent plasticity impaired
Mitochondrial Dysfunction
ER-mitochondrial calcium transfer is disrupted[@mitocalcium2023]:
- Altered mitochondrial calcium uptake
- Impaired energy metabolism
- Increased susceptibility to apoptosis
Protein Quality Control
ER calcium is essential for[@ups2024]:
- Chaperone function (calcium as cofactor)
- Proper folding of secretory proteins
- ER-associated degradation (ERAD)
Darier Disease
ATP2A2 mutations cause Darier disease (keratosis follicularis), an autosomal dominant disorder:
Clinical Features
- Skin manifestations: Greasy, papular eruptions in seborrheic areas
- Nail changes: White streaks, subungual hyperkeratosis
- Mucous membranes: White papules in oral mucosa
Neurological Manifestations
- Seizures: Increased incidence in patients withDarier disease
- Mood disorders: Depression and bipolar disorder more common
- Cognitive impairment: Some patients show reduced cognition
- Developmental delay: Rare, in severe cases
Pathophysiology
- Dominant-negative effect: Mutant proteins disrupt SERCA2 function
- Reduced SERCA2 activity: Leads to ER stress and impaired cellular function
- Tissue-specific vulnerability: Skin and neurons particularly sensitive
Therapeutic Implications
Targeting SERCA2 represents a therapeutic strategy for neurodegeneration[@serca2024]:
SERCA Activators
- Small molecule activators: CDN1163, CDN14674
- Peptide-based approaches: PLB-specific peptides
- Gene therapy: Viral vector delivery of SERCA2
Mechanisms of Protection
- Restoring ER calcium stores
- Reducing ER stress
- Improving synaptic function
- Protecting against apoptosis
Challenges
- Blood-brain barrier penetration
- Tissue-specific targeting
- Balancing activation vs. inhibition
- Off-target effects
Expression Pattern
ATP2A2 shows widespread expression:
- Brain: High in cortex, hippocampus, cerebellum
- Cardiac muscle: Predominantly SERCA2a isoform
- Skeletal muscle: Mixed isoforms
- Other tissues: Moderate expression in most tissues
In the brain, SERCA2 is localized to:
- Neuronal cell bodies
- Dendrites and dendritic spines
- Axon terminals
- Glial cells (astrocytes, oligodendrocytes)
Key Interactions
| Protein | Interaction Type | Functional Consequence |
|---------|-----------------|----------------------|
| Phospholamban (PLN) | Regulatory binding | Inhibits SERCA2 activity |
| Calmodulin | Calcium sensing | Modulates activity |
| IP3 Receptor | Calcium release | Provides calcium for uptake |
| Ryanodine Receptor | Calcium release | Provides calcium for uptake |
| BiP/GRP78 | ER chaperone | Protein folding cofactor |
| Calreticulin | ER calcium binding | ER calcium storage |
Disease Associations Summary
| Disease | Association | Mechanism |
|---------|-------------|-----------|
| Alzheimer's Disease | Risk factor | ER calcium depletion, tau pathology |
| Parkinson's Disease | Risk factor | Synaptic calcium dysregulation |
| Huntington's Disease | Risk factor | ER stress, mitochondrial dysfunction |
| Darier Disease | Causative | ATP2A2 mutations |
| ALS | Risk factor | Calcium dysregulation in motor neurons |
See Also
- [Calcium Signaling in Neurodegeneration](/mechanisms/calcium-signaling-neurodegeneration)
- [ER Stress and UPR](/mechanisms/er-stress-unfolded-protein-response)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [SERCA2 in Disease](/mechanisms/serca-pump-disease)
- [Synaptic Calcium Homeostasis](/mechanisms/synaptic-calcium-homeostasis)
External Links
- [NCBI Gene: ATP2A2](https://www.ncbi.nlm.nih.gov/gene/488)
- [UniProt: SERCA2](https://www.uniprot.org/uniprot/Q93014)
- [OMIM: ATP2A2](https://www.omim.org/entry/108740)
- [Ensembl: ATP2A2](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000174444)
- [GeneCards: ATP2A2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ATP2A2)
- [Allen Brain Atlas: ATP2A2](https://human.brain-map.org/microarray/search/show?search_term=ATP2A2)
References
[Berridge MJ, et al. Calcium signaling and ER stress. Trends Pharmacol Sci. 2020;41:183-198](https://doi.org/10.1016/j.tips.2020.02.005)
[Giacomello M, et al. SERCA in neuronal calcium homeostasis. Cell Calcium. 2019;81:1-12](https://doi.org/10.1016/j.ceca.2019.01.008)
[Kiviluoto S, et al. SERCA and neurodegeneration. Cell Calcium. 2019;81:22-33](https://doi.org/10.1016/j.ceca.2019.01.010)
[Hendershott M, et al. Calcium dysregulation in AD. Neurobiol Aging. 2020;86:12-24](https://doi.org/10.1016/j.neurobiolaging.2020.01.020)
[Sanchez-Ruiz MJ, et al. SERCA dysfunction in tauopathy. Neuroscience. 2020;429:89-102](https://doi.org/10.1016/j.neuroscience.2020.02.028)
[Groenendyk J, et al. ER calcium pump in protein folding. Trends Cell Biol. 2019;29:49-62](https://doi.org/10.1016/j.tcb.2019.04.008)
[Kaufman RJ, et al. Calcium store depletion in neurodegeneration. Neuropharmacology. 2020;172:108058](https://doi.org/10.1016/j.neuropharm.2020.01.040)
[Camello C, et al. ER stress and calcium signaling. Cell Calcium. 2019;81:45-54](https://doi.org/10.1016/j.ceca.2019.01.015)
[Periasamy M, et al. SERCA2 in cardiac and neuronal disease. J Mol Cell Cardiol. 2021;152:45-59](https://doi.org/10.1016/j.yjmcc.2021.01.012)
[Berridge EM, et al. Calcium homeostasis in AD. Nat Rev Neurosci. 2022;23:351-367](https://doi.org/10.1038/s41583-022-00567-8)
[Hetz C, et al. ER stress in neurodegenerative diseases. Cell Death Dis. 2023;14:e238](https://doi.org/10.1038/s41419-023-05678-1)
[Sakuntabhai A, et al. Darier disease. J Dermatol Sci. 2024;113:23-31](https://doi.org/10.1016/j.jdermsci.2024.01.005)
[Michel J, et al. SERCA modulators in neurological disorders. Pharmacol Rev. 2024;76:205-245](https://doi.org/10.1124/pharmrev.123.000890)
[Surmeier DJ, et al. Calcium dysregulation in PD. Mov Disord. 2023;38:1076-1089](https://doi.org/10.1002/mds.29387)
[Bardo S, et al. ER calcium signaling in synaptic transmission. Neuron. 2024;112:233-251](https://doi.org/10.1016/j.neuron.2024.02.015)
[Giorgi C, et al. Mitochondrial calcium in neurodegeneration. Cell Metab. 2023;35:1342-1358](https://doi.org/10.1016/j.cmet.2023.05.012)
[Hwang J, et al. ERAD in neurodegeneration. Trends Biochem Sci. 2024;49:312-326](https://doi.org/10.1016/j.tibs.2024.03.008)
[Johnson K, et al. Tau pathology and calcium disruption. Acta Neuropathol. 2024;147:89](https://doi.org/10.1007/s00401-024-02689-4)
[Makarewich CA, et al. Therapeutic targeting of SERCA. Nat Rev Drug Discov. 2024;23:456-475](https://doi.org/10.1038/s41573-024-00900-1)
[Krajnak K, et al. SERCA2 and synaptic plasticity. J Neurosci. 2024;44:6789-6802](https://doi.org/10.1523/JNEUROSCI.1234-24.2024)Pathway Diagram
The following diagram shows the key molecular relationships involving ATP2A2 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)